Researchers at Indiana University School of Medicine have launched a new, unique study recruiting black women with breast cancer designed to better understand and treat neuropathy, a side effect from chemotherapy. The National Cancer Institute-sponsored clinical trial, EAZ171, is led by Bryan P. Schneider, MD, professor of medicine and medical and molecular genetics and the […]
The post Trial seeks to reduce neuropathy, improve outcomes for black women with breast cancer appeared first on Newsroom.
When Jay Hess first arrived at Indiana University School of Medicine as dean six years ago, he received a meeting request from Hal Broxmeyer, one of the school’s legendary researchers who is internationally celebrated as the father of umbilical cord transplants. Hess suspected Broxmeyer—at the time closing in on 70 years old—might want to share […]
The post IU School of Medicine researcher Hal Broxmeyer awarded IU President’s Medal appeared first on Newsroom.
INDIANAPOLIS — The Indiana University Melvin and Bren Simon Cancer Center has achieved the highest recognition from the National Cancer Institute: Comprehensive Cancer Center. With this elite federal designation signifying research excellence, it becomes the only NCI-designated Comprehensive Cancer Center in Indiana and one of just 51 in the nation. Dr. Douglas Lowy, acting director […]
The post IU Simon Cancer Center earns NCI’s Comprehensive Cancer Center designation appeared first on Newsroom.
Winners and losers. How cancer cells bully normal cells in body. A study published today in “Nature” shines new light on the aggressive growth of cancer cells—and identifies a way to potentially make tumors more susceptible to chemotherapy. A team of investigators helmed by Dr. Rajan Gogna from the Champalimaud Centre for the Unknown in […]
The post Study published in ‘Nature’ identifies new mechanism for cancer cell growth appeared first on Newsroom.
INDIANAPOLIS—The Chan Zuckerberg Initiative announced today that a team of Indiana University School of Medicine researchers is joining a select group of scientists, computational biologists, software engineers and physicians as winners of the CZI Seed Networks for the Human Cell Atlas awards. The research group is led by Harikrishna Nakshatri, PhD, the Marian J. Morrison […]
The post Chan Zuckerberg Initiative picks IU team for Human Cell Atlas award appeared first on Newsroom.
It is well understood that people with diabetes have an increased risk for a number of other health complications—including cancer. Last year, when Indiana University School of Medicine researchers demonstrated that inflammation can increase risk for leukemia, they wondered if it was also the culprit that placed people with diabetes at a higher risk for […]
The post Funding to help researchers study link between high blood sugar, cancer appeared first on Newsroom.
INDIANAPOLIS — A team of researchers from Indiana University and Memorial Sloan Kettering Cancer Center have been awarded a $4.1 million National Cancer Institute “Cancer Moonshot” grant to develop immunotherapy treatments for cancer in children and adolescents, especially those with leukemia. The research promises to achieve more effective, better targeted and less toxic therapies for […]
The post IU cancer researcher, collaborators earn $4.1 million grant from Cancer Moonshot appeared first on Newsroom.
INDIANAPOLIS — On a night when Chuck Pagano returned to Indianapolis, Colts owner Jim Irsay pledged $1 million to cancer research in his former coach’s honor, helping to raise more than $1.8 million to support scientists at the Indiana University Melvin and Bren Simon Cancer Center. Colts Chief Operating Officer Pete Ward made the announcement […]
The post Irsay gift pushes Chuckstrong Tailgate Gala past $1.8 million for cancer research appeared first on Newsroom.
Indiana University School of Medicine researcher Reuben Kapur, PhD, has received more than $1.8 million to research the mechanisms that lead to a rare blood cancer called acute myeloid leukemia (AML). Kapur will closely examine the interaction between certain cellular mutations believed to contribute to the development and relapse of AML. The grant was awarded by the National Cancer Institute and will support this project for the next five years. Kapur conducts his research at the Herman B Wells Center […]
The post Researchers receive $1.8 million to investigate progression, relapse of rare blood cancer appeared first on Newsroom.
Indiana University School of Medicine researcher Reuben Kapur, PhD, Frieda and Albrecht Kipp Professor of Pediatrics, has received more than $2 million to identify new targets in the rare pediatric blood cancer known as juvenile myelomonocytic leukemia or JMML. Kapur, who conducts his research at the Herman B Wells Center for Pediatric Research and the […]
The post Researchers receive $2 million to pursue targets in rare pediatric cancer appeared first on Newsroom.